Vogenx, Inc.
No enriched coverage for $VOGX in the last 7 days.
No SEC Form 4 filings for $VOGX in the last 30 days.
The article previews four US IPOs scheduled for the coming week: Braveheart Bio (BRVE) raising $300M at a $1.4B market cap, Attovia Therapeutics (ATTO) raising $200M at $649M, River City Bank (RCBC) raising $136M at $703M, and Vogenx (VOGX) raising $75M at $173M. It also notes SpaceX (SPCX) earnings and a partial lock-up release that will expand tradable float.
The pipeline milestones and trial start timing are the main drivers for valuation and post-IPO sentiment.
alphai scores every news story that mentions VOGX with an AI model for sentiment and relevance, and aggregates insider trades from Vogenx, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
The article previews four US IPOs scheduled for the coming week: Braveheart Bio (BRVE) raising $300M at a $1.4B market cap, Attovia Therapeutics (ATTO) raising $200M at $649M, River City Bank (RCBC) raising $136M at $703M, and Vogenx (VOGX) raising $75M at $173M. It also notes SpaceX (SPCX) earnings and a partial lock-up release that will expand tradable float.
6 min read